BioCardia Fills in a Key Piece of CardiaAmp Puzzle with New Clearance

BioCardia has filled in another piece of the CardiAmp Cell Therapy puzzle with a new clearance from FDA. The San Carlos, CA-based company has received a nod from the federal agency to market the Morph DNA deflectable guide catheter.